Literature DB >> 19820554

Electroconvulsive therapy: Part II: a biopsychosocial perspective.

Nancy A Payne1, Joan Prudic.   

Abstract

The myths surrounding electroconvulsive therapy (ECT) and the misconceptions held by the general public, clinicians, and patients have interfered with acceptance of this treatment throughout its history. Misunderstandings surrounding ECT, and its consequent stigmatization, are reviewed, including negative depictions of ECT in film, print media, and on the Internet. Clinicians involved in the delivery of ECT benefit from gaining an understanding of how ECT may be perceived by patients and other mental health professionals; they can play a vital role in educating patients and helping ensure the delivery of a successful course of ECT. Guidance is provided for clinicians on how to support patients and families through the ECT process using a model team approach. Anxiety reduction, meeting individual needs, patient and family psychoeducation, assessment of psychosocial supports, and discharge planning are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19820554      PMCID: PMC3069072          DOI: 10.1097/01.pra.0000361278.73092.85

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  62 in total

Review 1.  A review of continuation and maintenance electroconvulsive therapy.

Authors:  K Rabheru; E Persad
Journal:  Can J Psychiatry       Date:  1997-06       Impact factor: 4.356

2.  The cognitive effects of electroconvulsive therapy in community settings.

Authors:  Harold A Sackeim; Joan Prudic; Rice Fuller; John Keilp; Philip W Lavori; Mark Olfson
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

5.  Medical, judicial, and statutory regulation of ECT in the United States.

Authors:  W J Winslade; E H Liston; J W Ross; K D Weber
Journal:  Am J Psychiatry       Date:  1984-11       Impact factor: 18.112

6.  Marital dissatisfaction and incidence of major depressive episode in a community sample.

Authors:  M A Whisman; M L Bruce
Journal:  J Abnorm Psychol       Date:  1999-11

7.  Patient attitudes toward electroconvulsive therapy.

Authors:  H M Pettinati; T A Tamburello; C R Ruetsch; F N Kaplan
Journal:  Psychopharmacol Bull       Date:  1994

8.  The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.

Authors:  H A Sackeim; J Prudic; D P Devanand; P Decina; B Kerr; S Malitz
Journal:  J Clin Psychopharmacol       Date:  1990-04       Impact factor: 3.153

9.  Patients' fear of and objection to electroconvulsive therapy.

Authors:  H A Fox
Journal:  Hosp Community Psychiatry       Date:  1993-04

10.  Levels of expressed emotion and relapse in depressed patients.

Authors:  J M Hooley; J Orley; J D Teasdale
Journal:  Br J Psychiatry       Date:  1986-06       Impact factor: 9.319

View more
  15 in total

Review 1.  [Electroconvulsive therapy for the treatment of major depression].

Authors:  D Zilles; C Wolff-Menzler; J Wiltfang
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

2.  Electroconvulsive practice in Singapore: a cross-sectional national survey.

Authors:  Phern-Chern Tor; Verònica Gálvez; Aaron Ang; Johnson Fam; Herng-Nieng Chan; Sheng-Neng Tan; Colleen K Loo
Journal:  Singapore Med J       Date:  2019-06-14       Impact factor: 1.858

3.  Effect of supportive nursing care on self esteem of patients receiving electroconvulsive therapy: a randomized controlled clinical trial.

Authors:  Hossein Ebrahimi; Ali Navidian; Roghaieh Keykha
Journal:  J Caring Sci       Date:  2014-06-01

Review 4.  On the significance of electroconvulsive therapy in the treatment of severe mental diseases.

Authors:  Michael Grözinger; Elke Stefanie Smith; Andreas Conca
Journal:  Wien Klin Wochenschr       Date:  2015-03-03       Impact factor: 1.704

5.  [Effectiveness and tolerability of electroconvulsive therapy : Influence of clinical response from the patient's point of view].

Authors:  M Belz; M Besse; L Krech; I Methfessel; D Zilles
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

Review 6.  An overview on clinical aspects in magnetic seizure therapy.

Authors:  Alice Engel; Sarah Kayser
Journal:  J Neural Transm (Vienna)       Date:  2016-06-23       Impact factor: 3.575

7.  Brain stimulation in posttraumatic stress disorder.

Authors:  Vladan Novakovic; Leo Sher; Kyle A B Lapidus; Janet Mindes; Julia A Golier; Rachel Yehuda
Journal:  Eur J Psychotraumatol       Date:  2011-10-17

8.  Effects of ECT in treatment of depression: study protocol for a prospective neuroradiological study of acute and longitudinal effects on brain structure and function.

Authors:  Leif Oltedal; Ute Kessler; Lars Ersland; Renate Grüner; Ole A Andreassen; Jan Haavik; Per Ivar Hoff; Åsa Hammar; Anders M Dale; Kenneth Hugdahl; Ketil J Oedegaard
Journal:  BMC Psychiatry       Date:  2015-05-01       Impact factor: 3.630

9.  Supportive Nursing Care and Satisfaction of Patients Receiving Electroconvulsive Therapy: A Randomized Controlled Clinical Trial.

Authors:  Ali Navidian; Hossein Ebrahimi; Roghaieh Keykha
Journal:  Iran Red Crescent Med J       Date:  2015-09-28       Impact factor: 0.611

10.  The Effect of Counseling on Stigma in Psychiatric Patients Receiving Electroconvulsive Therapy: A Clinical Trial Study.

Authors:  Efat Sadeghian; Parisa Rostami; Farshid Shamsaei; Lily Tapak
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.